# Mesalamine

NDC: 68382-452
Generic name: Mesalamine
Labeler / Manufacturer: Zydus Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20210813

FDA application: ANDA208954

## Active ingredients

- MESALAMINE: .375 g/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68382-452"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68382-452
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd8493f7-91fd-4c2d-b3d7-c1301825586b